The influence of endogenous mineralocorticoids on the composition of fetal urine.
Experiments were carried out in 10 chronically catheterised fetal sheep aged 121-128 days. In 3 animals infusion of aldosterone (5 micrograms/h) caused a fall in fetal urinary Na/K ratio; an effect that was reversed by spironolactone 2.5 mg/kg followed by an infusion of 100 micrograms/h per kg. In 9 fetal sheep which had no previous treatment the same doses of spironolactone had no effect on fractional sodium excretion although the fractional excretion of potassium decreased (P less than 0.05) and the urinary sodium potassium (Na/K) ratio rose (P less than 0.05). Amiloride had a variable effect on sodium excretion but the fractional excretion of potassium decreased markedly (P less than 0.05). Thus in chronically catheterised fetal sheep, endogenous mineralocorticoid activity altered urinary potassium excretion and the urinary Na/K ratio. However this activity was low, as distal blockade with amiloride further decreased the fractional excretion of potassium and increased the urinary Na/K ratio.
Kairaitis
K
K
School of Physiology & Pharmacology, University of New South Wales, Australia.
Lumbers
E R
ER
D000450:Aldosterone / Q000494:pharmacology; D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D002712:Chlorides / Q000652:urine; D005260:Female; D005333:Fetus / Q000378:metabolism; D005919:Glomerular Filtration Rate; D008901:Mineralocorticoids / Q000378:metabolism*; D011188:Potassium / Q000652:urine; D011247:Pregnancy; D012756:Sheep / Q000196:embryology* / Q000652:urine; D012964:Sodium / Q000652:urine; D013148:Spironolactone / Q000494:pharmacology; D014556:Urine / Q000737:chemistry*
D002712:Chlorides; D008901:Mineralocorticoids; D013148:Spironolactone; D000450:Aldosterone; D000584:Amiloride; D012964:Sodium; D011188:Potassium